SERPINE1 and metabolic dysfunction-associated steatotic liver disease: DNAm PAI-1 (DNA methylation estimator of plasma PAI-1 levels) strongly predicts plasma lipid levels in type 2 diabetes mellitus, nonalcoholic fatty liver disease (NAFLD) and systemic hypertension [81].